CAPITAL IMPACT ADVISORS, LLC Supernus Pharmaceuticals, Inc. Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$760,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.03% -232 shares 109K $33.85 22.29K
Q2 2022 share Decrease -13.08% -3.38K shares -186K $28.92 22.52K
Q1 2022 share Increase 0.00% 25.91K shares 837K $32.32 25.91K
Q4 2021 share Decrease -100.00% -48.5K shares -1.29M $30.03 0
Q3 2021 share 0.00% 0 shares -200K $26.67 48.5K
Q2 2021 share 0.00% 0 shares 223K $30.79 48.5K
Q1 2021 share Increase 0.00% 48.5K shares 1.27M $26.18 48.5K
Q4 2020 share Decrease -100.00% -83.63K shares -1.74M $25.16 0
Q3 2020 share 0.00% 0 shares -243K $20.84 83.63K
Q2 2020 share 0.00% 0 shares 481K $23.75 83.63K
Q1 2020 share Increase +6.36% 5.00K shares -360K $17.99 83.63K
Q4 2019 share Increase +3.78% 2.86K shares -216K $23.72 78.63K
Q3 2019 share Increase +20.42% 12.84K shares 66K $27.48 75.76K
Q2 2019 share Increase +40.87% 18.25K shares 570K $33.09 62.91K
Q1 2019 share 0.00% 0 shares 0 $35.04 44.66K
Q4 2018 share Increase +8.93% 3.66K shares -603K $33.22 44.66K
Q3 2018 share Increase +8.58% 3.23K shares -156K $50.35 41.00K
Q2 2018 share Decrease -12.23% -5.26K shares 233K $59.85 37.76K
Q1 2018 share Increase +47.45% 13.84K shares 808K $45.8 43.02K
Q4 2017 share 0.00% 0 shares -4K $39.85 29.18K
Q3 2017 share 0.00% 0 shares -91K $40 29.18K
Q2 2017 share Decrease -27.70% -11.17K shares -5K $43.1 29.18K
Q1 2017 share Increase 0.00% 40.35K shares 1.26M $31.3 40.35K